TrialDiabetologia2024

A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.

Chantal Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.